Routes of administration

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Report - ResearchAndMarkets.com

Retrieved on: 
Friday, April 2, 2021
Pharmaceutical, Health, Medical devices, Health sciences, Pharmacology, Routes of administration, Dosage forms, Pharmaceutical sciences, Transdermal patch, Transdermal, Transdermal spray, Topical medication

The "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
  • "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020".
  • Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
  • The report reviews details of major pipeline products which includes product description, licensing and collaboration details and other developmental activities
    In-depth analysis of the product's current stage of development, territory and estimated launch date

United States Transdermal Patch Market Insights 2021-2026: Market Will Surpass $6 Billion - More Than 25 FDA Approved Patches Are Available In The US Market And More Than 40 Are In Clinical Trials

Retrieved on: 
Wednesday, March 31, 2021
Pharmacology, Health sciences, Routes of administration, Drugs, Prostate Adenocarcinoma: TransCutaneous Hormones, Transdermal patches, Patch

DUBLIN, March 31, 2021 /PRNewswire/ -- The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 31, 2021 /PRNewswire/ -- The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.
  • The US transdermal patch drug delivery market is associated with large number of major key players inclined towards developing transdermal patches for different diseases.
  • Some of the application-based advantages associated with the therapy are: painless, non-invasive, convenient, release of desirable disease and many more.
  • US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026 Report Highlights:
    US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase
    Number of Patch In Clinical Trials: > 40 Patch
    Marketed Transdermal Patch Clinical Insight: > 25 FDA Approved Patch
    3.

Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration

Retrieved on: 
Tuesday, March 30, 2021
Prostaglandins, Secondary alcohols, Treprostinil, Routes of administration, Injection, Subcutaneous injection, Subcutaneous, Health, Chemistry, Physical sciences

We worked hard to overcome this obstacle, and we can now offer generic Treprostinil Injection to more than double the number of PAH patients.

Key Points: 
  • We worked hard to overcome this obstacle, and we can now offer generic Treprostinil Injection to more than double the number of PAH patients.
  • Since commercial launch two years ago, Treprostinil Injection has only been used for intravenous administration.
  • The cartridges required to operate the only subcutaneous pump that could deliver treprostinil injection (CADD-MS 3) were not made available to patients using generic treprostinil injection.
  • CADD-MS 3 is a registered trademark of Smiths Medical ASD, Inc.
    Treprostinil Injection is the first-to-file, fully substitutable generic treprostinil for parenteral administration.

United States Transdermal Patch Market, Dosage, Price & Clinical Trials Insights 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 26, 2021
Pharmaceutical, Health, Medical Supplies, Pharmacology, Health sciences, Psychoactive drugs, Dosage forms, Routes of administration, Euphoriants, Transdermal patches, Stimulants, Patch, Nicotine

The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.
  • The US transdermal patch drug delivery market is associated with large number of major key players inclined towards developing transdermal patches for different diseases.
  • US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026 Report Highlights:
    US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase
    Number of Patch In Clinical Trials: > 40 Patch
    Marketed Transdermal Patch Clinical Insight: > 25 FDA Approved Patch
    3.
  • 4.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch

Global $9.3 Billion Enteral Feeding Formulas Market to 2028: Shifting Trend Towards Consumption of Disease Specific Formulas & Growing Demand for Neonatal and Preterm Enteral Feeding

Retrieved on: 
Wednesday, March 24, 2021
Enteral feeding, Preterm birth, Routes of administration, Enteral administration, Feeding tube, Medicine, Health sciences, Health

The global enteral feeding formulas market size is expected to reach USD 9.3 billion by 2028.

Key Points: 
  • The global enteral feeding formulas market size is expected to reach USD 9.3 billion by 2028.
  • In addition, the rise in preterm births is one of the significant factors boosting the demand for enteral feeding formulas to meet the nutritional requirements of newborns.
  • Based on product, the standard formulas segment dominated the market and accounted for the largest revenue share of 54.0% in 2020.
  • This high share is attributable to the availability of a vast variety of standard formulas coupled with increased demand for low-cost nutrient formulations.

US Transdermal Patch Market USD 6 Billion Opportunity By 2026

Retrieved on: 
Tuesday, March 23, 2021
Health sciences, Routes of administration, Pharmacology, Medicine, Dosage forms, Transdermal patch, Transdermal, Hisamitsu Pharmaceutical

"US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights:

Key Points: 
  • "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights:
    US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase
    Number of Patch In Clinical Trials: > 40 Patch
    Marketed Transdermal Patch Clinical Insight: > 25 FDA Approved Patch
    The US transdermal patch drug market is revolving due to two powerful mega-trends a dynamic acceleration in the total US pharmaceutical market growth and the significant contribution of the researchers for restructuring the entire healthcare sector to a system where the drug delivery mechanisms are modulated in an efficient way.
  • The US transdermal patch drug market is indeed a constructive sector for the entire US pharmaceutical market.
  • US transdermal patch drug market for the benefit of the patient population has been implementing several important strategies that could response to diversifying transdermal patch services in order to address the local need of the patients.
  • As per the extensive research conducted for US Transdermal patch drug market, it is estimated that several single as well as multi-pronged approach initiated by the country's pharmaceutical industry have generated mega-trends responsible for making the entire market sustain numerous phases of growth as well as extensive competitiveness in the global transdermal patch drug market.

US Transdermal Patch Market USD 6 Billion Opportunity By 2026

Retrieved on: 
Tuesday, March 23, 2021
Health sciences, Routes of administration, Pharmacology, Medicine, Dosage forms, Transdermal patch, Transdermal, Hisamitsu Pharmaceutical

"US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights:

Key Points: 
  • "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights:
    US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase
    Number of Patch In Clinical Trials: > 40 Patch
    Marketed Transdermal Patch Clinical Insight: > 25 FDA Approved Patch
    The US transdermal patch drug market is revolving due to two powerful mega-trends a dynamic acceleration in the total US pharmaceutical market growth and the significant contribution of the researchers for restructuring the entire healthcare sector to a system where the drug delivery mechanisms are modulated in an efficient way.
  • The US transdermal patch drug market is indeed a constructive sector for the entire US pharmaceutical market.
  • US transdermal patch drug market for the benefit of the patient population has been implementing several important strategies that could response to diversifying transdermal patch services in order to address the local need of the patients.
  • As per the extensive research conducted for US Transdermal patch drug market, it is estimated that several single as well as multi-pronged approach initiated by the country's pharmaceutical industry have generated mega-trends responsible for making the entire market sustain numerous phases of growth as well as extensive competitiveness in the global transdermal patch drug market.

India Drug Delivery Devices Market Forecast & Opportunities, FY2026: Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch) & Route of Administration (Oral Drug Delivery, Injectable Drug Delivery) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 23, 2021
Pharmaceutical, Health, Medical devices, Health sciences, Pharmacology, Medicine, Routes of administration, Dosage forms, Medical equipment, Pharmacokinetics, Transdermal patch, Transdermal, Route of administration, Drug delivery, Nebulizer

The "India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.
  • The Indian Drug Delivery Devices Market was valued at around USD564 million in FY2020 and is expected to grow at a steady CAGR of 8.05% during the forecast period.
  • The Indian Drug Delivery Devices Market is driven by growing use of drug delivery systems in healthcare facilities.
  • The Indian Drug Delivery Devices Market is segmented based on devices, route of administration, patient care setting, application, company, and region.

TearClear Moving Toward Clinical Trials and Strengthening Leadership Team

Retrieved on: 
Tuesday, March 16, 2021
Health sciences, Health, Food and Drug Administration, Prostaglandins, Pharmaceutical industry, Medical terminology, Routes of administration, Latanoprost, Topical medication, Clinical trial

With a successful Pre-IND meeting with the US FDA achieved in Nov. 2020, the TearClear team is now advancing the preparation of clinical trial material required for its proprietary latanoprost pivotal study in anticipation of an IND submission later this year.

Key Points: 
  • With a successful Pre-IND meeting with the US FDA achieved in Nov. 2020, the TearClear team is now advancing the preparation of clinical trial material required for its proprietary latanoprost pivotal study in anticipation of an IND submission later this year.
  • Today, TearClear also announces the appointment of Stuart Raetzman to interim CEO.
  • Stuart is a TearClear Board Member and long-term Industry veteran with a proven track record of building successful pharmaceutical businesses.
  • At TearClear, our goal is to disrupt the way current topical medications are delivered to the ocular surface.

How to Select the Right Polymers for your Modified Release Tablet or Capsule, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Friday, March 12, 2021
Health sciences, Pharmacology, Pharmaceutical sciences, Dosage forms, Pharmaceutical industry, Pharmacokinetics, Pharmacy, Routes of administration, Modified-release dosage, Tablet, Capsule, Excipient

Often, modified release (MR) formulations offer patient compliance, marketing and exclusivity/patent benefits over immediate-release versions.

Key Points: 
  • Often, modified release (MR) formulations offer patient compliance, marketing and exclusivity/patent benefits over immediate-release versions.
  • What isn't as obvious is that MR dosage forms present their own unique set of complications around excipient selection.
  • In this webinar, panelists will discuss the most common polymers used in modified release oral solid dosage form development.
  • For more information, or to register for this event, visit How to Select the Right Polymers for your Modified Release Tablet or Capsule.